SCHEMBL359437

SCHEMBL359437

CCCCCN1N=C(CN(C)C(=O)O)CC1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
THRB P10828 1/20 0.52
KDM4E B2RXH2 2/20 0.35
HTT P42858 2/20 0.35
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALOX5 P09917 1/20 0.34
BCHE P06276 2/20 0.32
PTPN1 P18031 1/20 0.32
ACP1 P24666 1/20 0.32
CDC25B P30305 1/20 0.32
SHMT2 P34897 1/20 0.32
PTGER4 P35408 4/20 0.32
PTGER3 P43115 3/20 0.32
PTGER2 P43116 2/20 0.32
OPRM1 P35372 1/20 0.32
POLB P06746 1/20 0.32
NAAA Q02083 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL359186 0.99 ALDH1A1 (0.51) ALDH1A1GAAMAPTTHRBKDM4E
SCHEMBL360695 0.99 ALDH1A1 (0.51) ALDH1A1GAAMAPTTHRBKDM4E
SCHEMBL361729 0.96 ALDH1A1 (0.47) ALDH1A1GAAMAPTTHRBKDM4E
SCHEMBL359796 0.82 LMNA (0.34) ALDH1A1GAAMAPTTHRBLMNA
SCHEMBL14916530 0.82 ALDH1A1 (0.45) ALDH1A1GAAMAPTTHRBKDM4E
SCHEMBL14916433 0.82 ALDH1A1 (0.45) ALDH1A1GAAMAPTTHRBKDM4E
SCHEMBL359878 0.82 ALDH1A1 (0.32) ALDH1A1GAAMAPTTHRB
SCHEMBL14916531 0.80 ALDH1A1 (0.46) ALDH1A1GAAMAPTTHRBKDM4E
SCHEMBL14916435 0.80 ALDH1A1 (0.46) ALDH1A1GAAMAPTTHRBKDM4E
SCHEMBL358852 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11312688-B2 Pyrazole compound SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-04-26 US disclosed
US-20200308119-A1 PYRAZOLE COMPOUND NEUROINNOVATECH APS (DK) 2020-10-01 US disclosed
US-10723703-B2 Pyrazole compound SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-07-28 US disclosed
US-20190084938-A1 PYRAZOLE COMPOUND NEUROINNOVATECH APS (DK) 2019-03-21 US disclosed
US-10183913-B2 Pyrazole compound SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2019-01-22 US disclosed
US-10087146-B2 Pyrazole compound SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2018-10-02 US disclosed
US-20180273489-A1 PYRAZOLE COMPOUND NEUROINNOVATECH APS (DK) 2018-09-27 US disclosed
US-20170217902-A1 PYRAZOLE COMPOUND NEUROINNOVATECH APS (DK) 2017-08-03 US disclosed
US-9663472-B2 Pyrazole compound SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2017-05-30 US disclosed
EP-2594559-B1 PYRAZOLE COMPOUND SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2016-02-24 EP disclosed
US-20140315971-A1 PYRAZOLE COMPOUND NEUROINNOVATECH APS (DK) 2014-10-23 US disclosed
US-8809383-B2 Pyrazole compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2014-08-19 US disclosed
US-20140031406-A1 PYRAZOLE COMPOUND DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2014-01-30 US disclosed
US-8569353-B2 Pyrazole compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-10-29 US disclosed
EP-2594559-A1 PYRAZOLE COMPOUND Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-05-22 EP disclosed
US-20130116296-A1 PYRAZOLE COMPOUND NEUROINNOVATECH APS (DK) 2013-05-09 US disclosed
WO-2012008528-A1 PYRAZOLE COMPOUND 大日本住友製薬株式会社 (JP) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140315971-A1 PYRAZOLE COMPOUND HTR2C, HTR3B, HTR3A ALDH1A1 2035/4885GAA 4858/4885MAPT 3845/4885
US-10183913-B2 Pyrazole compound HTR2C, HTR3B, HTR3A ALDH1A1 2035/4885GAA 4858/4885MAPT 3845/4885
US-20170217902-A1 PYRAZOLE COMPOUND HTR2C, HTR3B, HTR3A ALDH1A1 2035/4885GAA 4858/4885MAPT 3845/4885
US-11312688-B2 Pyrazole compound HTR2C, HTR3B, HTR3A ALDH1A1 2035/4885GAA 4858/4885MAPT 3845/4885
US-20130116296-A1 PYRAZOLE COMPOUND HTR2C, HTR3B, HTR3A ALDH1A1 2035/4885GAA 4858/4885MAPT 3845/4885
US-20200308119-A1 PYRAZOLE COMPOUND HTR2C, HTR3B, HTR3A ALDH1A1 2035/4885GAA 4858/4885MAPT 3845/4885
US-10723703-B2 Pyrazole compound HTR2C, HTR3B, HTR3A ALDH1A1 2035/4885GAA 4858/4885MAPT 3845/4885
US-20180273489-A1 PYRAZOLE COMPOUND HTR2C, HTR3B, HTR3A ALDH1A1 2035/4885GAA 4858/4885MAPT 3845/4885
US-20190084938-A1 PYRAZOLE COMPOUND HTR2C, HTR3B, HTR3A ALDH1A1 2035/4885GAA 4858/4885MAPT 3845/4885
US-10087146-B2 Pyrazole compound HTR2C, HTR3B, HTR3A ALDH1A1 2035/4885GAA 4858/4885MAPT 3845/4885
US-20140031406-A1 PYRAZOLE COMPOUND HTR2C, HTR3B, HTR3A ALDH1A1 2035/4885GAA 4858/4885MAPT 3845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.